Synthace and Ipsen partner to accelerate novel therapeutic development through automation
Two European leaders in biopharma and integrative software are working together to advance drug discovery
Two European leaders in biopharma and integrative software are working together to advance drug discovery
With intuitive workflows, quick setup, and expert support, Veya is making automation accessible and cost-effective for first-time users
Scientists from AstraZeneca, Bayer, Eli Lilly, Janssen, Roche, and other leading biopharma companies present on the latest topics biotherapeutic research and development
Analysis of antimicrobial resistance in 271 US hospitals finds higher rates of antibiotic-resistant infections in both COVID-19 patients and SARS-COV-2 negative patients admitted during the pandemic compared to pre-pandemic
Discover the latest tools and techniques to expand your research capacity with expert-led presentations on cancer research, mass spectrometry, deep phenotyping, and more
Find out how automation could transform and benefit your workflow, enabling you to focus on other tasks
Explore cutting-edge technologies and the latest resources to support your materials characterization
Watch this on-demand webinar to learn about a targeted profiling workflow for the nutrient evaluation of bovine serum samples as supplements in cell culture
Watch this on-demand webinar to learn how to take your nucleic acid quantification to the next level of speed, accuracy, and throughput
The range of high quality deep well plates are suited for researchers working in molecular biology, cell biology or drug discovery applications
Experts share tips on how to choose between quaternary and binary UPLC systems in our webinar later on Thursday, July 11
New Progeny ResQ FLX analyzer integrates latest drug identification technology to keep law enforcement safe while battling opioid epidemic